Halogen bonding helps design new drugs

“Scientists at the University of Tübingen, in cooperation with the MRC Laboratory of Molecular Biology in Cambridge / UK, have now demonstrated that halogen bonding can be used to identify potential drug candidates for cancer treatment. Dr. Rainer Wilcken and Prof. Frank Böckler in collaboration with Dr. Andreas Joerger and Prof. Sir Alan Fersht…” More…